HOTLINE II, ISAR-TEST-4 trial, biodegradable stent coatings show promise.
D020341:Absorbable Implants; D023903:Coronary Restenosis / Q000517:prevention & control*; D054855:Drug-Eluting Stents; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D020123:Sirolimus / Q000008:administration & dosage*; D050257:Tubulin Modulators / Q000008:administration & dosage*
D050257:Tubulin Modulators; D020123:Sirolimus